Description
Product Description
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) studied for its ability to stimulate the natural release of growth hormone (GH) from the pituitary gland. It has gained significant attention in metabolic and endocrine research for its role in regulating fat metabolism, body composition, and growth hormone signaling.
Injectable Tesamorelin (subcutaneous) to rapidly increase systemic peptide availability.
This protocol supports growth hormone regulation and metabolic balance from multiple biological angles.
Key Benefits:
- Growth Hormone Stimulation – Promotes the natural release of growth hormone from the pituitary gland
- Fat Metabolism – Studied for its effects on reducing visceral adipose tissue and improving metabolic health
- Body Composition – May support lean muscle mass maintenance and fat distribution balance
- Metabolic Regulation – Influences pathways involved in lipid metabolism and glucose regulation
- Endocrine Support – Supports the function of the hypothalamic–pituitary–growth hormone axis
Product Information
Product Name: Tesamorelin
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight: 5135.9 g/mol
CAS Number: 218949-48-5
Synonym: TH9507, Growth Hormone-Releasing Factor Analog, Tesamorelin Acetate
Intro
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), designed to stimulate the pituitary gland to release endogenous growth hormone. By mimicking the activity of natural GHRH, Tesamorelin activates receptors in the pituitary gland that regulate growth hormone secretion.
Growth hormone plays an important role in metabolism, body composition, cellular repair, and protein synthesis. Through the stimulation of growth hormone release, Tesamorelin indirectly increases levels of insulin-like growth factor 1 (IGF-1), a hormone involved in tissue growth and metabolic regulation.
Research has particularly focused on Tesamorelin’s effects on visceral adipose tissue, which is the fat stored around internal organs and associated with metabolic disease risk.
Because of its role in growth hormone signaling and metabolic regulation, Tesamorelin has become an important compound in research exploring body composition, metabolic health, and endocrine function.
The Science
Tesamorelin functions by binding to growth hormone-releasing hormone (GHRH) receptors located in the anterior pituitary gland. Activation of these receptors stimulates the pituitary to release growth hormone into the bloodstream.
Once released, growth hormone acts on multiple tissues throughout the body, including the liver, where it promotes the production of insulin-like growth factor 1 (IGF-1). IGF-1 mediates many of the anabolic and metabolic effects associated with growth hormone signaling.
Through this pathway, Tesamorelin enhances lipolysis, the breakdown of stored fat, particularly within visceral adipose tissue. This process contributes to improved metabolic function and body composition.
Additionally, growth hormone signaling influences protein synthesis, cellular repair mechanisms, and metabolic regulation.
By stimulating endogenous growth hormone production rather than supplying growth hormone directly, Tesamorelin supports the natural regulatory pathways of the endocrine system.
Dosing Protocol
Injectable Tesamorelin (Subcutaneous)
Concentration: Approx. 5 mg per vial (standard)
Dosage: 1–2 mg per administration
Administration: Subcutaneously into the abdomen
Duration: Daily administration for 4–8 weeks
Buy Tesamorelin at Platinum Research Compounds
At Platinum Research Compounds, we provide research-grade Tesamorelin formulated to meet strict purity and stability standards. Our peptide formulations are designed for researchers, clinicians, and advanced users exploring growth hormone peptides and metabolic research compounds.
From secure packaging to responsive support, our commitment to quality and integrity makes us a trusted source for research peptides in Australia.
Product FAQ
What is Tesamorelin used for?
Tesamorelin is studied for its ability to stimulate growth hormone release and influence body composition and metabolic regulation.
What conditions is it being studied for?
Research has explored Tesamorelin in studies related to visceral fat reduction, metabolic disorders, endocrine regulation, and body composition.
Is it safe?
Clinical studies have demonstrated a favorable safety profile when used in controlled settings. However, it should only be used in approved research or supervised environments.
Does Tesamorelin increase growth hormone levels?
Tesamorelin stimulates the pituitary gland to release endogenous growth hormone, which may increase circulating growth hormone and IGF-1 levels.
